![Page 1: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/1.jpg)
Gastroenteropancreatic neuroendocrine tumors
(GEP – NET)
prof. Marek Bolanowski, Marek Bolanowski, MD, PhD
Department of Endocrinology, Diabetes and Isotope Therapy
ED yr V
Internal diseases, endocrinology
![Page 2: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/2.jpg)
Carcinoid
• Jahrestagung der Deutschen Gesellschaft für
Pathologie, Dresden, 17.09.1907
• Siegfried Oberndorfer (1875-1944)
• Karzinoide – carcinoma-like
![Page 3: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/3.jpg)
Neuroendocrine tumors - NETs
• Heterogenous group of neoplasms deriving from the cells of disseminated neuroendocrine system in various organs.
• APUD (amine precursors uptake and decarboxylation)
• Neuroendocrine tumors originating from GI system, lungs and thymus – traditionally carcinoids.
• Poorly differentiated NETs - very aggressive course.
• Well differentiated NETs - slowly growing.
• Ability to produce and secrete metabolically active substances causing certain clinical symptoms.
• Sporadic / familial syndromes.
![Page 4: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/4.jpg)
Gastroenteropancreatic tumors (GEP - NETs)
Epidemiology
• Incidence: 90 / 1 000 000 / yr
• Prevalence: 200-300 / 1 000 000
• Autopsy: 84 / 1 000 000
• (70% of NETs and 2% of GI neoplasms)
• Each age, peak in 6th decade
• Carcinoids - about 50%
![Page 5: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/5.jpg)
Embryological characteristics of GEP-NETs
• Foregut
(anterior part of the alimentary canal)
respiratory system, thymus,
stomach, duodenum, pancreas
• Midgut
(middle part of the alimentary canal)
small intestine, appendix,
ascending colon
• Hindgut
(posterior part of the alimentary canal)
transverse colon, sigmoideum,
rectum
Foregut
Midgut
Hindgut
![Page 6: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/6.jpg)
Clinical characteristics of GEP-NETs
• Secreting tumors
• hormones, peptides, kinins...
• Non-secreting tumors
• Carcinoids
![Page 7: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/7.jpg)
Clinical characteristics of secreting GEP-NETs
• Insulinoma
• Gastrinoma
• Glucagonoma
• VIP-oma
• Somatostatinoma
• PP-oma
![Page 8: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/8.jpg)
Tumor type, frequency and malignancy
Tumor type Frequency
(%)
Malignancy (%)
Carcinoid 50 90
Insulinoma 15 10
Gastrinoma 5 55
Glucagonoma 2 80
VIP-oma 1 80
Somatostatinoma 1 50
Non-functional ≈ 30 70
![Page 9: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/9.jpg)
Insulinoma
• most common pancreatic islets tumor from beta cells
• insulin secretion in excess
• hypoglycemia
• headache, confusion, visual disturbances, weakness,
sweating, tremor, palpitations, consciousness loss, coma
• weight gain
• fasting test – 72 hrs.
• malignant - rare (10%)
• multifocal (10%)
![Page 10: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/10.jpg)
Gastrinoma
• duodenal or pancreatic tumor
• in 5% atypical location
• gastrin secretion in excess
• gastric acid hypersecretion, recurrent peptic ulcers of
stomach, duodenum or of atypical location, diarrhea
(Zollinger-Ellison syndrome)
• possible ACTH secretion - Cushing’s syndrome
• in 1/3 as a part of MEN-1
• sporadic forms – malignant up to 40-80%
![Page 11: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/11.jpg)
Glucagonoma
• pancreatic islet tumor from alfa cells
• necrolytic migratory erythema, rash and hyperpigmentation
of mouth and genital region (80%)
• often thrombo-embolic episodes
• frank diabetes, glucose intolerance
• depression…
![Page 12: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/12.jpg)
VIP-oma – Verner-Morrison syndrome
• originates from autonomic nervous system cells
• possible localization in pancreas, nervous system or
adrenals
• VIP (vasoactive intestinal polypeptide) secretion
• watery diarrhea, hypokalemia, achlorhydria - WDHA
![Page 13: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/13.jpg)
Somatostatinoma
• from pancreatic islets D cells
• somatostatin (SS) secretion
• women/men 2:1
• fatty stools, fatty diarrhea, cholelithiasis, abdominal pain
• diabetes, hypochlorhydria
• gallbladder functional disturbances, weight loss
![Page 14: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/14.jpg)
PP-oma
• tumor secreting pancreatic polypeptide - PP
• asymptomatic usually
• diarrhea possible
• weight loss
• diabetes rare
![Page 15: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/15.jpg)
Other
• Neurotensinoma hypotension, tachycardia, cyanosis, oedema, vasodilatation,
diabetes
• Ghrelinoma hyperglycemia, insulin deficiency, insulin resistance, GH/IGF-1
excess, acromegaly, gastric acid hypersecretion, intestinal movements disturbances
• ACTH, GRF (GHRH), PTH, CT, LH, MSH
• CGRP, PTHrP,
• EG, CCK, GIP, GRP, NKA
![Page 16: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/16.jpg)
Non-secreting tumors (hormonally inactive)
• non-specific symptoms
abdominal pain
mechanical icterus (jaundice)
motility disturbances
![Page 17: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/17.jpg)
Clinical symptoms of NETs
• flushing episodes 84%
• diarrhea 79%
• valvular heart defects 37%
• bronchospasm 17%
• miopathy 7%
• pigmentation, arthropathy 5%
• hyperglycemia, hypoglycemia, peptic ulcer
disease, rash, exanthema < 1%
![Page 18: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/18.jpg)
![Page 19: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/19.jpg)
Carcinoid
• According to new classification carcinoid
(most common GEP tumor) = serotonin
secreting tumor originating from midgut,
only.
![Page 20: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/20.jpg)
Carcinoid
• Intestine wall, pancreas, appendix, colon, rectum,
stomach, duodenum, lungs, bronchi, ovary, thymus ...
• Often with metastases
• < 1 cm – metastases in 15%
• > 2 cm – metastases in 95%
• Episodic occurrence of symptoms
• 10 years from first symptoms to diagnosis
![Page 21: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/21.jpg)
Carcinoid syndrome symptoms
• in less than 10% patients with carcinoid
• more often in small intestine tumors
![Page 22: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/22.jpg)
Arthritis
(7%)
Skin lesions
(5%)
Diarrhea (68-84%)
Cyanosis
(18%)
Heart lesions
(14-41%)
Flushing (63-94%)
Teleangiectasiae
(25%)
Bronchospasm
(3-19%)
Abdominal pain
(10-55%)
Carcinoid syndrome symptoms site and frequency
![Page 23: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/23.jpg)
Differential diagnostics
• heart failure (dyspnoea)
• pheochromocytoma (skin lesions)
• thyroid medullary carcinoma (diarrhea)
• diabetic neuropathy
• menopause (flush)
• epilepsy
• panic, fear
![Page 24: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/24.jpg)
Laboratory diagnostics
• urinary 5-HIAA excretion
• serum serotonin concentration
• serum chromogranins A, B and C
• CgA – prognostic marker of survival
• CgB – marker of benign insulinoma
• neuron-specific enolase – NSE, synaptophysin, PGP 9.5
• insulin, gastrin, VIP, glucagon levels
• CA-19 - malignancy marker
![Page 25: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/25.jpg)
Histology of GEPs (WHO)
1. Well differentiated neuroendocrine tumor 1A with benign course
1B with benign or potentially malignant course
2. Well differentiated neuroendocrine cancer (low malignancy)
3. Poorly differentiated neuroendocrine cancer (high malignancy)
![Page 26: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/26.jpg)
Imaging
• spiral CT
• MRI
• US (endoscopic) + biopsy
• capsule endoscopy
• double-balloon enteroscopy
• somatostatin receptors scintigraphy (OctreoScan)
• angiography
• PET
![Page 27: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/27.jpg)
Somatostatin receptors scintigraphy
![Page 28: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/28.jpg)
Treatment
Surgery – therapy of choice
• cytoreductive surgery: tumor resection, ablative radiotherapy, cryotherapy
• aims: stop of tumor growth, biochemical normalization, quality of life improvement
Pharmacotherapy
Specific treatment of secreting tumors
Radioisotope therapy
![Page 29: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/29.jpg)
Somatostatin analogs
Anti-neoplastic activity
• Direct (SS receptors)
• Indirect
• growth factors inhibition
• influence on immunological system
• apoptosis induction
• angiogenesis inhibition
![Page 30: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/30.jpg)
Somatostatin analogs
• Clinical improvement in 30-85% of patients
• Decline in level of markers in 50%
• Stabilization of tumor growth in 40-80%
• Tumor regression in 5%
![Page 31: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/31.jpg)
Somatostatin analogs
• Octreotide
Sandostatin (i.v. 2-3 times daily)
Sandostatin LAR 10, 20, 30 mg (i.m. every 28 days)
• Lanreotide
Somatuline LP 30 mg (s.c. every 14 days)
Somatuline Autogel 60, 90, 120 mg (s.c. every 28-56 days)
• Pasireotide
• Vapreotide
![Page 32: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/32.jpg)
Duration of action of somatostatin analogs single dose
Octreotide
Somatuline PR
Octreotide LAR
Somatuline
Autogel
Duration of action (days)
Up to 56 days
for ATG 120 mg
![Page 33: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/33.jpg)
Somatostatin analogs in practice
• Receptors presence
• Hormones-related symptoms
• Origin from foregut and midgut
• Carcinoid syndrome
• VIP-oma, glucagonoma
• Malignant gastrinoma and insulinoma
• GHRH secreting tumors (acromegaly)
Acute therapy (fast and short acting analogs)
Chronic therapy in order to decrease of the symptoms (long-acting
analogs)
![Page 34: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/34.jpg)
Interferon alfa
Anti-neoplastic activity
• Influence on proliferation, differentiation, apoptosis and
angiogenesis
• Metastasis fibrosis induction (liver)
• Control of clinical symptoms and biochemical response
in 46-77%
Possible administration together with
somatostatin analogs
![Page 35: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/35.jpg)
Other therapies
Radioisotope therapy • 125I-MIBG, 131I-MIBG
• 111I-DTPA-octreotide – indium labelled SS analog
• 90Y-DOTA-TOC – radionuclide emiting beta radiation binding to SS receptors type 2 and type 5
Specific therapy of secreting tumors • diazoxide, streptozotocine
• proton pump inhibitors (PPI), histamine receptor antagonists
![Page 36: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/36.jpg)
Effects of 90Y/177Lu DOTA-TATE therapy
Before therapy After therapy
![Page 37: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/37.jpg)
Chemotherapy
• In patients with advanced disease
• Poorly differentiated pancreatic tumors, especially
• Chlorozotocine, streptozotocine, 5-FU, adriamycine, lomustine, doxorubicine
![Page 38: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/38.jpg)
Treatment - perspectives
• Angiogenesis inhibitors – VEGF (vascular endothelium growth factor) and VEGF receptors
• Thyrosine kinase inhibitors – (sunitinib, imatinib, gefinitib)
• Inhibitors of serine-treonine protein kinase mTOR (mammalian target of rapamycin) – immunosuppression, inhibition of proliferation and survival of neoplastic cell (everolimus)
• Monoclonal antibodies (bevacizumab)
• Temozolomide
![Page 39: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/39.jpg)
Unfavorable prognostic factors of GEP-NETs
• Age >50, males
• Site: pancreas, rectum
• Tumor size and penetration depth
• Metastases, radical therapy impossible
• Clinical symptoms
• Carcinoid syndrome symptoms
• High markers (CgA, 5-HIAA, CT, gastrin, ACTH)
• High proliferative index
![Page 40: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/40.jpg)
Multiple endocrine neoplasia
Well-characterized, inherited, plurihormonal disorders
with simultaneous neoplastic transformation and
hyperfunction of several endocrine glands.
• family history, hereditary
• germline DNA testing
• MEN-I (mutation inactivating the menin tumor suppressor on
chromosome 11q13)
• MEN-II a (activating mutation of RET protooncogene on
chromosome 10q11.2)
• MEN-II b (RET mutation at codon 918 – exon 16)
![Page 41: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/41.jpg)
MEN-I
• rare, autosomal dominant condition
• well differentiated, benign tumors
• parathyroid glands
• pancreas (islet tumors)
• pituitary (adenomas)
• duodenum
• adrenal cortex
– bronchial, thymic NETs
– dermal lesions, thyroid disease, meningeal tumors…
![Page 42: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/42.jpg)
MEN-I
• Pituitary 45%
• Skin 75%
• Parathyroids
89%
• Gastrointestinal
system 54%
• Adrenals 18%
![Page 43: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/43.jpg)
MEN-IIa
Neoplastic transformation of:
• parathyroids
• thyroid parafollicular C cells
• adrenal medulla
• hyperparathyroidism
• medullary thyroid carcinoma
• pheochromocytoma
• Increased mortality (mean age 60 yrs)
![Page 44: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/44.jpg)
MEN-IIb
Neoplastic transformation of:
• thyroid parafollicular C cells
• adrenal medulla
• multiple mucosal neuromas
• medullary thyroid carcinoma
• pheochromocytoma
• Marfanoid signs
• High mortality (mean age 30 yrs)
![Page 45: Gastroenteropancreatic neuroendocrine tumors (GEP NET ...€¦ · stomach, duodenum, pancreas ... • most common pancreatic islets tumor from beta cells • insulin secretion in](https://reader035.vdokument.com/reader035/viewer/2022070113/605bdfe57ed7f41e571f1547/html5/thumbnails/45.jpg)
Other disorders with multiple endocrine organs involvement
Carney complex
• cardiac, endocrine, cutaneus and neural tumors
• myxomas (heart, breast, skin), spotty pigmentation of the skin
• primary pigmented micronodular adrenocortical hyperplasia
• pituitary, adrenals, thyroid and testes tumors
Neurofibromatosis type 1 (Recklinghausen disease)
• cafe au lait spots, neurofibromas, gliomas,
• endocrine tumors (pheo, hyperparathyroidism, MTC, carcinoids)
von Hippel-Lindau disease
• hemangioblastomas (retinal, cerebellar)
• renal cell carcinoma, islet cell tumors, pheochromocytoma
• cysts (renal, pancreatic, epidydymal)